Psychiatric Illness and Virologic Response in Patients Initiating Highly Active Antiretroviral Therapy

Abstract

These results are consistent with an inferior virologic response to first HAART among patients with concurrent mood, anxiety, and substance use disorders, suggesting a clinical benefit to identification and treatment of psychiatric illness among patients initiating antiretroviral therapy.